Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bill would give device center $40.4 million more in FY '09

This article was originally published in The Silver Sheet

Executive Summary

CDRH would receive in fiscal year 2009 an additional $40.4 million over the previous year's funding levels under a bill that passed the Senate Appropriations Committee July 17. The measure would give FDA a total of $2.04 billion in appropriations for FY 2009, including $278.4 million for the device center and related field activities. That means the agency would have $324.6 million more for FY 2009 than in FY 2008 - and $5.2 million more than President Bush requested. With the expanded FDA funding, the committee wants $104 million spent on device, drug and biologic safety to increase overseas and domestic inspections, and $40 million to upgrade science programs across the agency. The House Appropriations Committee has yet to sign off on funding levels, and Chairman David Obey, D-Wis., has suggested that a continuing resolution is likely ("The Silver Sheet" July 2008)
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT036260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel